Metabolic Syndrome May Increase Women’s Risk of Endometrial Cancer

A recent study found that women diagnosed with metabolic syndrome using criteria set by the US National Cholesterol Education Program Adult Treatment Panel III (ATP III) were 39% more likely to develop endometrial cancer, while those diagnosed using International Diabetes Foundation criteria were 109% more likely to develop the cancer. After adjusting for overweight/obesity, women with metabolic syndrome under ATP III and International Diabetes Foundation criteria were 21% and 17% more likely to be diagnosed with endometrial cancer, respectively. The Cancer Epidemiology, Biomarkers & Prevention study pertained to 16,323 US women with endometrial cancer and 100,751 women without cancer.

Category:
Subcategory:
Body:

A recent study found that women diagnosed with metabolic syndrome using criteria set by the US National Cholesterol Education Program Adult Treatment Panel III (ATP III) were 39% more likely to develop endometrial cancer, while those diagnosed using International Diabetes Foundation criteria were 109% more likely to develop the cancer. After adjusting for overweight/obesity, women with metabolic syndrome under ATP III and International Diabetes Foundation criteria were 21% and 17% more likely to be diagnosed with endometrial cancer, respectively. The Cancer Epidemiology, Biomarkers & Prevention study pertained to 16,323 US women with endometrial cancer and 100,751 women without cancer.

Area(s) of Interest: